PROCEPT BioRobotics Corporation Capital Expenditures Incurred but Not yet Paid
PROCEPT BioRobotics Corporation (PRCT) reported Capital Expenditures Incurred but Not yet Paid of $121.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$940.00K.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.06M, a 23.56% decline year-over-year.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $255.00K, a 21.05% decline year-over-year.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $101.00K.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for fiscal 2025 was $969.00K, a 178.45% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for fiscal 2024 was $348.00K, a 81.32% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for fiscal 2023 was $1.86M, a 47.43% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation capital expenditures incurred but not yet paid for fiscal 2022 was $3.54M, a 1587.62% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$940.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $121.00K 10-Q · filed 2026-08-05 | $376.00K derived: sum of 3 quarters · filed 2026-08-05 | $477.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-04-30 | $1.32M derived: sum of 2 quarters · filed 2026-04-30 | $1.42M derived: sum of 3 quarters · filed 2026-04-30 | $642.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $356.00K derived: sum of 2 quarters · filed 2026-02-26 | -$419.00K derived: sum of 3 quarters · filed 2026-08-05 | $969.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$674.00K derived: sum of 2 quarters · filed 2026-08-05 | $714.00K 10-Q · filed 2025-11-05 | $1.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $613.00K 10-Q · filed 2026-08-05 | $936.00K derived: sum of 3 quarters · filed 2026-08-05 | $880.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.39M 10-Q · filed 2026-04-30 | $1.71M derived: sum of 2 quarters · filed 2026-04-30 | $1.66M derived: sum of 3 quarters · filed 2026-04-30 | $1.18M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $267.00K derived: sum of 2 quarters · filed 2026-02-26 | -$211.00K derived: sum of 3 quarters · filed 2026-02-26 | $348.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$534.00K derived: sum of 2 quarters · filed 2025-11-05 | $25.00K 10-Q · filed 2025-11-05 | -$5.95M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $81.00K 10-Q · filed 2025-08-07 | -$5.89M derived: sum of 3 quarters · filed 2026-02-26 | -$12.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $559.00K 10-Q · filed 2025-05-02 | -$5.42M derived: sum of 2 quarters · filed 2026-02-26 | $466.00K derived: sum of 3 quarters · filed 2026-02-26 | $153.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$93.00K derived: sum of 2 quarters · filed 2026-02-26 | -$406.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.86M 10-K · filed 2026-02-26 |
| 2023-09-30 | $5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $5.57M derived: sum of 2 quarters · filed 2024-10-28 | $7.84M 10-Q · filed 2024-10-28 | $11.18M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$313.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.96M 10-Q · filed 2024-08-02 | $5.30M derived: sum of 3 quarters · filed 2025-02-27 | $4.93M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.27M 10-Q · filed 2024-05-02 | $5.61M derived: sum of 2 quarters · filed 2025-02-27 | $5.25M derived: sum of 3 quarters · filed 2025-02-27 | $5.46M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.98M derived: sum of 2 quarters · filed 2025-02-27 | $3.19M derived: sum of 3 quarters · filed 2025-02-27 | $3.54M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$151.00K derived: sum of 2 quarters · filed 2023-11-02 | $200.00K 10-Q · filed 2023-11-02 | $210.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $566.00K 10-Q · filed 2023-07-28 | $576.00K derived: sum of 3 quarters · filed 2024-02-28 | $550.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $351.00K 10-Q · filed 2023-05-04 | $361.00K derived: sum of 2 quarters · filed 2024-02-28 | $335.00K derived: sum of 3 quarters · filed 2024-02-28 | $361.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$16.00K derived: sum of 2 quarters · filed 2024-02-28 | $10.00K derived: sum of 3 quarters · filed 2024-02-28 | $210.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $200.00K 10-Q · filed 2022-11-04 | $210.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $226.00K 10-Q · filed 2022-08-05 | $236.00K derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-06 | $210.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $210.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |